Issue Price
₹20
Per Share
GMP
NIL
Grey Market
Est. Listing
₹20
Expected Price
Min. Application
₹240,000
2 lots × 6000 shares
Incorporated in 1996, Achyut Healthcare Limited is engaged in the trading of Pharmaceutical Products. The company has business operations in both domestic and international markets in the countries namely UAE, Kenya, and Nigeria. The company is located in Ahmedabad, Gujarat.The company involves in the trading of Cenzure, Arpimune, Azathioprine IP, Everomimus, Mycophenolate Mofetil USP, Mycophenolate Sodium USP, Sirolimus, Tacrolimus USP, Infrared thermometer, Ascorbic Acid Coated Vitamin C, Calcium carbonate oyster, Cellulose acetate Phthalate, Chlorthalidone IP, Cross Carmalose Sod IP/USP, DI Basic Calcium Phosphate IP, DI Ethyl Phthlate, Diltiazem Hydrochloride IP, Easy Coat Fc Titanium Dioxide, Escitalopram IP, Escitalopram Oxalate, Favipiravir among many other products.Competitive Strengths:Pan India and Global market presence.Long-standing relationship with our customers having an exponentially strong rise and reach.Experienced management team with proven project management and implementation skills.Multi-location facilities have aided in market penetration and developing a strong presence in India and abroad.
Achyut Healthcare Ltd. proposes to utilise the net proceeds from the Issue for the following objects:
| Category | Shares Offered | % Issue | Amount (₹ Cr)* | Subscription |
|---|---|---|---|---|
| Market Maker | 96,000 | — | ₹0.19 Cr | — |
| TOTAL | 1,800,000 | 100.00% | ₹3.60 Cr | — |
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 6,000 | ₹120,000 |
| Retail (Max) | 13 | 78,000 | ₹1,560,000 |
| sNII (Min) | 14 | 84,000 | ₹1,680,000 |
| bNII (Min) | 68 | 408,000 | ₹8,160,000 |
| Particulars | 30-Sep-21 | 31-Mar-21 | 31-Mar-20 |
|---|---|---|---|
| Revenue from Operations | 272.54 | 27.43 | 34.56 |
| EBITDA | N/A | N/A | N/A |
| Profit After Tax (PAT) | 12.63 | 0.74 | 1.40 |
| Net Worth | N/A | N/A | N/A |
| Total Assets | 588.68 | 47.13 | 27.26 |
| Reserves & Surplus | N/A | N/A | N/A |
| Total Borrowings | N/A | N/A | N/A |